AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -68.6% | 15,385 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -20.5% | 15,385 | 0.0% | 0.00% | – |
| Q3 2021 | $44,000 | -24.1% | 15,385 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | +11.5% | 15,385 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +20.9% | 15,385 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | +10.3% | 15,385 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -81.3% | 15,385 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $209,000 | +78.6% | 15,385 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $117,000 | +53.9% | 15,385 | +27.5% | 0.00% | – |
| Q4 2019 | $76,000 | +61.7% | 12,065 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -19.0% | 12,065 | 0.0% | 0.00% | – |
| Q2 2019 | $58,000 | -41.4% | 12,065 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $99,000 | +47.8% | 12,065 | 0.0% | 0.00% | – |
| Q4 2018 | $67,000 | – | 12,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |